The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome

J Infect Dis. 1995 May;171(5):1360-3. doi: 10.1093/infdis/171.5.1360.

Abstract

A prospective study of parvovirus B19 infection during pregnancy was conducted at a large teaching hospital in Barcelona, Spain. Women (1610) who were < 28 weeks pregnant at enrollment were screened for parvovirus infection. The prevalence of IgG positivity was 35.03% (564/1610). The incidence of acute infection during pregnancy was 3.7% (60/1610). There were five abortions among the B19-infected women but only one was caused by parvovirus, as assessed by histologic examination and polymerase chain reaction assay. The incidence of fetal loss caused by parvovirus was, therefore, 1.66% (1/60). The remaining 55 pregnancies were uneventful, and at 1 year of age, none of the infants had serious abnormalities. The incidence of vertical transmission of infection was estimated at 25%. This study provides evidence that although acute parvovirus infection may occur relatively commonly during pregnancy, an adverse fetal outcome is a rare complication.

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • Erythema Infectiosum / epidemiology*
  • Erythema Infectiosum / transmission
  • Female
  • Fetal Blood
  • Fetus / virology
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Parvovirus B19, Human / immunology
  • Parvovirus B19, Human / isolation & purification*
  • Pregnancy
  • Pregnancy Complications, Infectious / epidemiology*
  • Pregnancy Outcome
  • Prevalence
  • Prospective Studies
  • Spain / epidemiology

Substances

  • Antibodies, Viral